Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | -1.54% |
|
-5.88% | -8.83% |
Jul. 01 | Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) added to Russell Small Cap Comp Value Index | CI |
Jul. 01 | Aldeyra Therapeutics, Inc.(NasdaqCM:ALDX) added to Russell 3000 Value Index | CI |
Chart calendar Aldeyra Therapeutics, Inc.
Upcoming events on Aldeyra Therapeutics, Inc.
No events available
Past events on Aldeyra Therapeutics, Inc.
2024-06-20 08:00 am | Investor Meeting |
2024-06-05 03:30 pm | Jefferies Global Healthcare Conference |
2024-06-04 08:00 am | Annual General Meeting |
2024-04-25 09:00 am | R&D Day |
2024-03-28 08:00 am | Business Update Call |
2024-02-13 04:00 pm | Oppenheimer Healthcare Life Sciences Conference |
2023-12-19 08:00 am | ADX?629 Phase 2 Clinical Trial Call |
2023-11-28 08:00 am | Business Update Call |
2023-07-10 | SVB Securities Therapeutics Forum |
2023-06-30 08:00 am | Annual General Meeting |
2023-06-29 08:00 am | ADX?2191 Phase 2 Clinical Trial Results Call |
2023-06-27 08:00 am | ADX?629 Phase 2 clinical Trial Results Call |
2023-06-15 08:00 am | INVIGORATE?2 Phase 3 Trial Results Call |
2023-06-09 09:30 am | Jefferies Global Healthcare Conference |
2023-05-04 07:00 am | Q1 2023 Earnings Release |
2023-03-09 08:00 am | Q4 2022 Earnings Call |
2023-03-09 07:00 am | Q4 2022 Earnings Release |
2023-02-16 10:00 am | SVB Securities Global Biopharma Conference |
2022-11-10 08:00 am | Q3 2022 Earnings Call |
2022-11-10 07:00 am | Q3 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,43 - | 24,9 |
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -56,0 -56,5 0.92% | -62,4 -64,3 2.94% | 0,00 -41,0 - | -41,9 |
EBIT Million USD | Released Forecast Spread | -63,1 -69,2 8.79% | -36,4 -35,4 -2.95% | -56,2 -57,1 1.52% | -62,7 -67,7 7.42% | -42,8 -46,5 7.96% | -27,9 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -62,1 -67,7 8.28% | -38,0 -37,0 -2.9% | -57,8 -58,5 1.32% | -62,0 -68,6 9.64% | -37,5 -42,7 12.06% | -22,0 |
Net income Million USD | Released Forecast Spread | -60,8 -66,4 8.45% | -37,6 -37,0 -1.6% | -57,8 -58,7 1.5% | -62,0 -68,5 9.39% | -37,5 -40,9 8.26% | -10,6 |
EPS USD | Released Forecast Spread | -2,24 -2,42 7.53% | -1,11 -1,09 -1.72% | -1,07 -1,09 1.95% | -1,06 -1,16 8.88% | -0,64 -0,70 7.91% | -0,19 |
Announcement Date | 12/03/20 | 11/03/21 | 17/03/22 | 09/03/23 | 07/03/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 2,43 - | 0,00 1,00 - | 0,00 | 0,00 | 24,9 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -4,50 | -9,33 -7,44 -25.42% | -10,1 | -10,8 | -11,6 | |||||||||
EBIT Million USD | Released Forecast Spread | -16,5 -16,5 0.11% | -17,7 -18,1 1.93% | -14,8 -20,8 29.03% | -13,7 -19,3 28.86% | -16,8 -16,8 0.14% | -10,3 -17,9 42.21% | -9,55 -14,6 34.7% | -6,10 -9,80 37.78% | -9,39 -8,88 -5.77% | -9,87 | -11,0 | 2,49 | -12,0 | -12,0 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -16,8 -16,9 0.57% | -17,8 -18,3 2.98% | -14,6 -20,9 30.53% | -12,9 -19,5 33.85% | -15,6 -17,0 8.01% | -8,99 -17,5 48.65% | -8,19 -13,9 40.89% | -4,75 -9,90 51.98% | -8,08 -8,31 2.73% | -9,10 | -10,2 | 5,36 | -10,5 | -10,5 |
Net income Million USD | Released Forecast Spread | -16,8 -18,9 11.31% | -17,8 -18,5 4.01% | -14,6 -20,8 29.89% | -12,9 -19,3 33.22% | -15,6 -17,0 8.24% | -8,99 -17,9 49.8% | -8,19 -14,0 41.42% | -4,75 -8,15 41.66% | -8,08 -6,83 -18.26% | -9,03 | -10,4 | 16,8 | -10,5 | -10,5 |
EPS USD | Released Forecast Spread | -0,29 -0,33 10.96% | -0,30 -0,32 5.26% | -0,25 -0,35 28.57% | -0,22 -0,32 31.61% | -0,27 -0,29 6.36% | -0,15 -0,30 50.55% | -0,14 -0,24 40.85% | -0,08 -0,14 42.17% | -0,14 -0,11 -24.05% | -0,15 | -0,17 | 0,26 | -0,17 | -0,17 |
Announcement Date | 05/05/22 | 05/08/22 | 10/11/22 | 09/03/23 | 04/05/23 | 03/08/23 | 03/11/23 | 07/03/24 | 02/05/24 | - | - | - | - | - |
Past sector events for Aldeyra Therapeutics, Inc.
2024-06-05 03:51 am | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ALDX Stock
- Calendar Aldeyra Therapeutics, Inc.